Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-05-18 Purchase |
2021-05-18 8:23 pm |
Vera Therapeutics Inc. | VERA | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. HEALY JAMES POWELL MICHAEL 10% Owner |
727,272 | $11 | $7,999,992 | 2,914,776 (Direct) |
View |
| 2021-02-09 Purchase |
2021-02-09 6:04 pm |
Bolt Biotherapeutics Inc. | BOLT | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. Katabi Maha POWELL MICHAEL 10% Owner |
450,000 | $20 | $9,000,000 | 2,754,437 (Direct) |
View |
| 2020-08-11 Purchase |
2020-08-12 9:04 pm |
Checkmate Pharmaceuticals Inc. | CMPI | POWELL MICHAEL Sofinnova Venture Partners IX L.P. Sofinnova Management IX L.L.C. HEALY JAMES Director 10% Owner |
133,333 | $15 | $1,999,995 | 3,606,707 (Indirect) |
View |
| 2020-07-28 Purchase |
2020-07-28 6:08 pm |
Inozyme Pharma Inc. | INZY | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. HEALY JAMES Katabi Maha POWELL MICHAEL 10% Owner |
437,500 | $16 | $7,000,000 | 2,028,308 (Direct) |
View |
| 2020-06-30 Purchase |
2020-07-01 9:36 pm |
Akouos Inc. | AKUS | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. HEALY JAMES Katabi Maha POWELL MICHAEL 10% Owner |
58,823 | $17 | $999,991 | 1,515,073 (Direct) |
View |
| 2020-06-01 Sale |
2020-06-03 8:20 pm |
Iterum Therapeutics plc | ITRM | Sofinnova Venture Partners IX L.P. Sofinnova Management IX L.L.C. HEALY JAMES POWELL MICHAEL 10% Owner |
500,000 | $1.6242 | $812,080 | 1,226,514 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2024-09-12 9:16 pm |
N/A 2034-08-06 |
Bicara Therapeutics Inc. | BCAX | POWELL MICHAEL Director |
0 | $0 | 59,501 (Direct) |
View |
| 2023-06-14 Option Award |
2023-06-16 4:15 pm |
N/A 2033-06-13 |
Galera Therapeutics Inc. | GRTX | POWELL MICHAEL Director |
64,000 | $0 | 64,000 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-16 4:05 pm |
N/A 2032-06-14 |
Galera Therapeutics Inc. | GRTX | POWELL MICHAEL Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-08-09 Option Award |
2021-08-10 4:05 pm |
N/A 2031-08-09 |
Checkmate Pharmaceuticals Inc. | CMPI | POWELL MICHAEL Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-21 9:18 pm |
N/A 2031-06-16 |
Checkmate Pharmaceuticals Inc. | CMPI | POWELL MICHAEL Director |
10,030 | $0 | 10,030 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-17 6:39 pm |
N/A 2031-06-15 |
Galera Therapeutics Inc. | GRTX | POWELL MICHAEL Director |
13,179 | $0 | 13,179 (Direct) |
View |
| 2021-05-18 Conversion |
2021-05-18 8:23 pm |
N/A N/A |
Vera Therapeutics Inc. | VERA | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. HEALY JAMES POWELL MICHAEL 10% Owner |
2,187,504 | $0 | 2,914,776 (Direct) |
View |
Ownership |
2021-05-13 7:30 pm |
N/A N/A |
Vera Therapeutics Inc. | VERA | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. HEALY JAMES POWELL MICHAEL 10% Owner |
0 | $0 | 2,187,504 (Direct) |
View |
| 2021-02-09 Conversion |
2021-02-09 6:04 pm |
N/A N/A |
Bolt Biotherapeutics Inc. | BOLT | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. Katabi Maha POWELL MICHAEL 10% Owner |
2,304,437 | $0 | 2,754,437 (Direct) |
View |
Ownership |
2021-02-04 8:59 pm |
N/A N/A |
Bolt Biotherapeutics Inc. | BOLT | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. Katabi Maha POWELL MICHAEL 10% Owner |
0 | $0 | 2,304,437 (Direct) |
View |
| 2020-11-10 Option Award |
2020-11-12 5:20 pm |
N/A 2030-11-09 |
Checkmate Pharmaceuticals Inc. | CMPI | POWELL MICHAEL Director 10% Owner |
30,000 | $0 | 30,000 (Direct) |
View |
| 2020-08-11 Conversion |
2020-08-12 9:04 pm |
N/A N/A |
Checkmate Pharmaceuticals Inc. | CMPI | POWELL MICHAEL Sofinnova Venture Partners IX L.P. Sofinnova Management IX L.L.C. HEALY JAMES Director 10% Owner |
28,371,348 | $0 | 3,606,707 (Indirect) |
View |
Ownership |
2020-08-06 9:12 pm |
N/A N/A |
Checkmate Pharmaceuticals Inc. | CMPI | POWELL MICHAEL Sofinnova Venture Partners IX L.P. Sofinnova Management IX L.L.C. HEALY JAMES Director 10% Owner |
0 | $0 | 3,473,374 (Indirect) |
View |
| 2020-07-28 Conversion |
2020-07-28 6:08 pm |
N/A N/A |
Inozyme Pharma Inc. | INZY | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. HEALY JAMES Katabi Maha POWELL MICHAEL 10% Owner |
13,478,920 | $0 | 2,028,308 (Direct) |
View |
Ownership |
2020-07-23 9:31 pm |
N/A N/A |
Inozyme Pharma Inc. | INZY | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. HEALY JAMES POWELL MICHAEL Katabi Maha 10% Owner |
0 | $0 | 1,590,808 (Direct) |
View |
| 2020-06-30 Conversion |
2020-07-01 9:36 pm |
N/A N/A |
Akouos Inc. | AKUS | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. HEALY JAMES Katabi Maha POWELL MICHAEL 10% Owner |
32,143,835 | $0 | 1,515,073 (Direct) |
View |
Ownership |
2020-06-25 9:26 pm |
N/A N/A |
Akouos Inc. | AKUS | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. HEALY JAMES POWELL MICHAEL 10% Owner |
0 | $0 | 1,456,250 (Direct) |
View |
| 2020-06-09 Option Award |
2020-06-10 5:19 pm |
N/A 2030-06-08 |
Galera Therapeutics Inc. | GRTX | POWELL MICHAEL Director 10% Owner |
13,179 | $0 | 13,179 (Indirect) |
View |